Vivos Inc. announces peer-reviewed PrecisionGel™ polymer platform paper
Vivos Inc. (OTCQB: RDGL) said a peer-reviewed paper describing its PrecisionGel™ thermogel polymer platform was published in Elsevier’s Journal of Drug Delivery Science and Technology.
Kennewick, WA, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Vivos Inc.
OTCQB:RDGL, a medical device company developing Precision Radionuclide Therapy™ (PRnT) for cancerous tumors in humans and animals, today announced the peer-reviewed publication of a paper describing the PrecisionGel™ thermogel polymer pla…